{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:49Z","timestamp":1792784929061,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Primary Care, Region Uppsala","award":["APCF-1028696"],"award-info":[{"award-number":["APCF-1028696"]}]},{"name":"Swedish Medical Association","award":["SLS-999315"],"award-info":[{"award-number":["SLS-999315"]}],"id":[{"id":"https:\/\/ror.org\/04hdh0n29","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Post-COVID-19 symptoms are common following COVID-19, but risk factors of persistent symptoms in patients with asthma and chronic obstructive lung disease (COPD) remain unclear. We aimed to assess the frequency and risk factors of post-COVID-19 symptoms in patients with asthma and COPD. In this cross-sectional study, we used data from the Swedish PRAXIS study collected in 2022. The cohort included randomly selected adult patients with a diagnosis of asthma or COPD in medical records from central Sweden\u2019s primary and secondary care. Participants completed a comprehensive questionnaire, and their responses were analysed. We used logistic regression and adjusted for age and lung disease diagnoses. Among 494 patients with confirmed COVID-19, 59% (289\/494) reported post-COVID-19 symptoms. Risk factors for post-COVID-19 symptoms included severe acute infection (adjusted odds ratio aOR: 8.91, 95% confidence interval [CI]: 3.49\u201322.8), higher age (aOR:1.25, 95% CI: 1.09\u20131.45), female sex (aOR: 1.52, 95% CI: 1.04\u20132.21), and obesity [BMI\u2009\u2265\u200930] (aOR: 2.24, 95% CI: 1.44\u20133.47)). Anxiety\/depression (aOR:1.79, 95% CI: 1.13\u20132.80) and chronic pain (aOR: 3.61, 95% CI: 1.95\u20136.69) were also significant risk factors. Patients with asthma or COPD had a high prevalence of post-COVID-19 symptoms compared to other studies. Several demographic and clinical factors were associated with post-COVID-19 symptoms, which could help identify patients at increased risk.<\/jats:p>","DOI":"10.1038\/s41533-026-00570-x","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:04:46Z","timestamp":1790647486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors of post-COVID-19 symptoms, a cross-sectional study in patients with asthma and chronic obstructive lung disease"],"prefix":"10.1038","volume":"36","author":[{"given":"Agnes","family":"Andreason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"St\u00e4llberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Lisspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Sandelowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefin","family":"Sundh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Eliason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5093-6980","authenticated-orcid":false,"given":"Christer","family":"Janson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-1509","authenticated-orcid":false,"given":"Marta","family":"A. Kisiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"570_CR1","unstructured":"Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Available from: https:\/\/ginasthma.org (2025)."},{"key":"570_CR2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available at: https:\/\/goldcopd.org (2025)"},{"key":"570_CR3","unstructured":"National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence; 2024. Available at: https:\/\/www.nice.org.uk\/guidance\/ng188."},{"key":"570_CR4","doi-asserted-by":"publisher","first-page":"e000723","DOI":"10.1136\/bmjmed-2023-000723","volume":"3","author":"JVA Franco","year":"2024","unstructured":"Franco, J. V. A. et al. Post-covid-19 conditions in adults: systematic review and meta-analysis of health outcomes in controlled studies. BMJ Med. 3, e000723 (2024).","journal-title":"BMJ Med."},{"key":"570_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04050-w","volume":"23","author":"S Lee","year":"2025","unstructured":"Lee, S. et al. Using machine learning involving diagnoses and medications as a risk prediction tool for post-acute sequelae of COVID-19 (PASC) in primary care. BMC Med. 23, 251 (2025).","journal-title":"BMC Med."},{"key":"570_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59012-w","volume":"16","author":"LL O\u2019Mahoney","year":"2025","unstructured":"O\u2019Mahoney, L. L. et al. The risk of long covid symptoms: a systematic review and meta-analysis of controlled studies. Nat. Commun. 16, 4249 (2025).","journal-title":"Nat. Commun."},{"key":"570_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04498-w","volume":"23","author":"S Lindblom","year":"2025","unstructured":"Lindblom, S. et al. Prevalence of depression, anxiety, fatigue, and headache before and after long COVID onset: a case-control study in the total population of region Stockholm. BMC Med. 23, 633 (2025).","journal-title":"BMC Med."},{"key":"570_CR8","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","volume":"187","author":"MJ Peluso","year":"2024","unstructured":"Peluso, M. J. & Deeks, S. G. Mechanisms of long COVID and the path toward therapeutics. Cell 187, 5500\u20135529 (2024).","journal-title":"Cell"},{"key":"570_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41392-023-01640-z","volume":"8","author":"J Li","year":"2023","unstructured":"Li, J. et al. The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Signal. Transduct. Target. Ther. 8, 416 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"570_CR10","doi-asserted-by":"publisher","first-page":"00133","DOI":"10.1183\/23120541.00133-2026","volume":"12","author":"S Chakraverty","year":"2026","unstructured":"Chakraverty, S. et al. Rehabilitation in long COVID: a systematic review and meta-analysis. ERJ Open. Res. 12, 00133\u201302026 (2026).","journal-title":"ERJ Open. Res."},{"key":"570_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19264-5","volume":"24","author":"R Sk Abd Razak","year":"2024","unstructured":"Sk Abd Razak, R. et al. Post-COVID syndrome prevalence: a systematic review and meta-analysis. BMC Public. Health 24, 1785 (2024).","journal-title":"BMC Public. Health"},{"key":"570_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijid.2022.11.021","volume":"126","author":"M Bygdell","year":"2023","unstructured":"Bygdell, M. et al. A comprehensive characterization of patients diagnosed with post-COVID-19 condition in Sweden 16 months after the introduction of the international classification of diseases tenth revision diagnosis code (U09.9): a population-based cohort study. Int. J. Infect. Dis. 126, 104\u2013113 (2023).","journal-title":"Int. J. Infect. Dis."},{"key":"570_CR13","doi-asserted-by":"publisher","first-page":"e002528","DOI":"10.1136\/bmjresp-2024-002528","volume":"12","author":"P Terry","year":"2025","unstructured":"Terry, P., Heidel, R. E., Wilson, A. Q. & Dhand, R. Risk of long covid in patients with pre-existing chronic respiratory diseases: a systematic review and meta-analysis. BMJ Open. Respir. Res. 12, e002528 (2025).","journal-title":"BMJ Open. Respir. Res."},{"key":"570_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.rmed.2017.10.010","volume":"132","author":"J Sundh","year":"2017","unstructured":"Sundh, J. et al. Health-related quality of life in asthma patients - a comparison of two cohorts from 2005 and 2015. Respir. Med. 132, 154\u2013160 (2017).","journal-title":"Respir. Med."},{"key":"570_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41533-020-0168-0","volume":"30","author":"MA Kisiel","year":"2020","unstructured":"Kisiel, M. A. et al. Data-driven questionnaire-based cluster analysis of asthma in Swedish adults. NPJ Prim. Care Respir. Med. 30, 14 (2020).","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"570_CR16","unstructured":"Folkh\u00e4lsomyndigheten. Varianter av viruset som orsakar covid-19. https:\/\/www.folkhalsomyndigheten.se\/smittskydd-beredskap\/smittsamma-sjukdomar\/covid-19\/varianter-av-viruset-som-orsakar-covid-19\/. (2024)."},{"key":"570_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/npjpcrm.2016.73","volume":"26","author":"J Sundh","year":"2016","unstructured":"Sundh, J. et al. Change in health status in COPD: a seven-year follow-up cohort study. NPJ Prim. Care Respir. Med. 26, 16073 (2016).","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"570_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"YHY Benjamini","year":"1995","unstructured":"Benjamini, Y. H. Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Society: Ser. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Society: Ser. B"},{"key":"570_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/apa.16535","volume":"112","author":"JF Ludvigsson","year":"2023","unstructured":"Ludvigsson, J. F. How Sweden approached the COVID-19 pandemic: summary and commentary on the national commission inquiry. Acta Paediatr. 112, 19\u201333 (2023).","journal-title":"Acta Paediatr."},{"key":"570_CR20","doi-asserted-by":"publisher","first-page":"e0260652","DOI":"10.1371\/journal.pone.0260652","volume":"16","author":"MA Kisiel","year":"2021","unstructured":"Kisiel, M. A. et al. Patterns and predictors of sick leave among Swedish non-hospitalized healthcare and residential care workers with Covid-19 during the early phase of the pandemic. PLoS One 16, e0260652 (2021).","journal-title":"PLoS One"},{"key":"570_CR21","doi-asserted-by":"publisher","first-page":"ofae424","DOI":"10.1093\/ofid\/ofae424","volume":"11","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Chronic lung disease as a risk factor for long COVID in patients diagnosed with coronavirus disease 2019: A Retrospective Cohort Study. Open. Forum Infect. Dis. 11, ofae424 (2024).","journal-title":"Open. Forum Infect. Dis."},{"key":"570_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/jamainternmed.2023.0750","volume":"183","author":"V Tsampasian","year":"2023","unstructured":"Tsampasian, V. et al. Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern. Med. 183, 566\u2013580 (2023).","journal-title":"JAMA Intern. Med."},{"key":"570_CR23","doi-asserted-by":"publisher","first-page":"611 e9","DOI":"10.1016\/j.cmi.2021.11.002","volume":"28","author":"F Bai","year":"2022","unstructured":"Bai, F. et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin. Microbiol. Infect. 28, 611 e9\u2013e16 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"570_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12020-020-02536-6","volume":"71","author":"MS Mohamed","year":"2021","unstructured":"Mohamed, M. S., Moulin, T. C. & Schioth, H. B. Sex differences in COVID-19: the role of androgens in disease severity and progression. Endocrine 71, 3\u20138 (2021).","journal-title":"Endocrine"},{"key":"570_CR25","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/jmv.25989","volume":"92","author":"F Zeng","year":"2020","unstructured":"Zeng, F. et al. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex. J. Med. Virol. 92, 2050\u20132054 (2020).","journal-title":"J. Med. Virol."},{"key":"570_CR26","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3390\/v16091369","volume":"16","author":"D Xu","year":"2024","unstructured":"Xu, D. & Qin, X. Type I interferonopathy among non-elderly female patients with post-acute sequelae of COVID-19. Viruses 16, 1369 (2024).","journal-title":"Viruses"},{"key":"570_CR27","doi-asserted-by":"publisher","first-page":"2300200","DOI":"10.2807\/1560-7917.ES.2024.29.2.2300200","volume":"29","author":"CE Gebhard","year":"2024","unstructured":"Gebhard, C. E. et al. Impact of sex and gender on post-COVID-19 syndrome, Switzerland, 2020. Euro Surveill. 29, 2300200 (2024).","journal-title":"Euro Surveill."},{"issue":"Suppl 1","key":"570_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.arbres.2022.03.011","volume":"58","author":"E Chiner-Vives","year":"2022","unstructured":"Chiner-Vives, E. et al. Short and long-term impact of COVID-19 infection on previous respiratory diseases. Arch. Bronconeumol. 58(Suppl 1), 39\u201350 (2022).","journal-title":"Arch. Bronconeumol."},{"key":"570_CR29","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","volume":"28","author":"A Subramanian","year":"2022","unstructured":"Subramanian, A. et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 28, 1706\u20131714 (2022).","journal-title":"Nat. Med."},{"key":"570_CR30","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","volume":"404","author":"T Greenhalgh","year":"2024","unstructured":"Greenhalgh, T., Sivan, M., Perlowski, A. & Nikolich, J. Z. Long COVID: a clinical update. Lancet 404, 707\u2013724 (2024).","journal-title":"Lancet"},{"key":"570_CR31","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/eurheartj\/ehac031","volume":"43","author":"B Raman","year":"2022","unstructured":"Raman, B., Bluemke, D. A., Luscher, T. F. & Neubauer, S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 43, 1157\u20131172 (2022).","journal-title":"Eur. Heart J."},{"key":"570_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30836-0","volume":"13","author":"EJ Thompson","year":"2022","unstructured":"Thompson, E. J. et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 13, 3528 (2022).","journal-title":"Nat. Commun."},{"key":"570_CR33","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s15010-022-01784-0","volume":"50","author":"SH Loosen","year":"2022","unstructured":"Loosen, S. H. et al. Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients. Infection 50, 1165\u20131170 (2022).","journal-title":"Infection"},{"key":"570_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/oby.23099","volume":"29","author":"RW O\u2019Rourke","year":"2021","unstructured":"O\u2019Rourke, R. W. & Lumeng, C. N. Pathways to severe COVID-19 for people with obesity. Obesity 29, 645\u2013653 (2021).","journal-title":"Obesity"},{"key":"570_CR35","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.3390\/jcm12113617","volume":"12","author":"MA Kisiel","year":"2023","unstructured":"Kisiel, M. A. et al. Clustering analysis identified three long COVID phenotypes and their association with general health status and working ability. J. Clin. Med. 12, 3617 (2023).","journal-title":"J. Clin. Med."},{"key":"570_CR36","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamapsychiatry.2022.2640","volume":"79","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions. JAMA Psychiatry 79, 1081\u20131091 (2022).","journal-title":"JAMA Psychiatry"},{"key":"570_CR37","doi-asserted-by":"publisher","unstructured":"Kisiel M. A. et al. Predictors of post-COVID-19 and the impact of persistent symptoms in non-hospitalized patients 12 months after COVID-19, with a focus on work ability. Ups J Med Sci. 127 https:\/\/doi.org\/10.48101\/ujms.v127.8794 (2022).","DOI":"10.48101\/ujms.v127.8794"},{"key":"570_CR38","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1097\/j.pain.0000000000003110","volume":"165","author":"RS Bergmans","year":"2024","unstructured":"Bergmans, R. S. et al. Chronic overlapping pain conditions increase the risk of long COVID features, regardless of acute COVID status. Pain 165, 1112\u20131120 (2024).","journal-title":"Pain"},{"key":"570_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijid.2023.08.019","volume":"136","author":"S Diexer","year":"2023","unstructured":"Diexer, S. et al. Association between virus variants, vaccination, previous infections, and post-COVID-19 risk. Int. J. Infect. Dis. 136, 14\u201321 (2023).","journal-title":"Int. J. Infect. Dis."},{"key":"570_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijid.2023.10.022","volume":"137","author":"J Agergaard","year":"2023","unstructured":"Agergaard, J., Gunst, J. D., Schiottz-Christensen, B., Ostergaard, L. & Wejse, C. Long-term prognosis at 1.5 years after infection with wild-type strain of SARS-CoV-2 and alpha, delta, as well as omicron variants. Int. J. Infect. Dis. 137, 126\u2013133 (2023).","journal-title":"Int. J. Infect. Dis."},{"key":"570_CR41","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano, J. B., Murthy, S., Marshall, J. C., Relan, P. & Diaz, J. V. Condition WHOCCDWGoP-C-. a clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22, e102\u2013e107 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"570_CR42","doi-asserted-by":"publisher","first-page":"e000385","DOI":"10.1136\/bmjmed-2022-000385","volume":"2","author":"O Byambasuren","year":"2023","unstructured":"Byambasuren, O., Stehlik, P., Clark, J., Alcorn, K. & Glasziou, P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2, e000385 (2023).","journal-title":"BMJ Med."}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00570-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00570-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00570-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:27:51Z","timestamp":1790648871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00570-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["570"],"URL":"https:\/\/doi.org\/10.1038\/s41533-026-00570-x","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"7 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Competing InterestsA.A., S.M., H.S., G.E., A.N., M.K., no conflict of interest. C.J. has received honoraria for educational activities and lectures from AstraZeneca, Chiesi, GlaxoSmithKline, Orion and Sanofi outside the submitted work.J.S. has received personal fees for educational activities from AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis and Takeda.K.L. has received payments from AstraZeneca, Novartis and Boehringer Ingelheim for educational activities and from AstraZeneca and Boehringer Ingelheim for partcipating in advisory boards.B.S. declare no competing financial or non-financial interests associated with this work. Outside the submitted work, B.S. has received personal fees for educational activities and lectures from AstraZeneca, Boehringer Ingelheim, Novartis, and GlaxoSmithKline and served on advisory boards arranged by AstraZeneca, Novartis, GlaxoSmithKline, and Boehringer Ingelheim.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used M365 Copilot and Grammarly to edit the language. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the published article.","order":2,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the manuscript preparation process","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"64"}}